---
$id: https://graph.org.ai/products/commodity/51131606
$type: Product
source: UNSPSC
code: "51131606"
title: "Sodium apolate"
class: "51131600"
classTitle: "Anticoagulants"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Sodium apolate

**UNSPSC Code**: 51131606
**Class**: [Anticoagulants](Anticoagulants.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticoagulant agent and a alkyl sulfonate, phosphogluconate dehydrogenase antagonists and inhibitor, polyvinyl, polyethylene, and sulfonic acid with the molecular formula C2H3NaO3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9461405D9F, chemically known as sodium;ethenesulfonate but generally known as sodium apolate, which bears US NIH Compound Identifier 3270262. European Medicines Agency schedules Sodium Apolate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05545MIG. The term SODIUM APOLATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Vol 20 1966, List 6). Most nations schedule sodium apolate under HS 39019090 and SITC 57190. SMILES: C=CS(=O)(=O)[O-].[Na+]

